Activities
VICH Steering Committee
Next meetings
45th SC meeting
16 – 19 November 2026 (Tsukuba City, Ibaraki prefecture, Japan)
46th SC meeting
fall 2027 in Europe – location TBD
VICH Forum
Next meetings:
19th VICH Forum meeting
17 & 18 November 2026 (Ibaraki, Japan)
Public Conference
8th VICH PUBLIC CONFERENCE
TBC
Concept papers currently being discussed by SC
- September 2024: VICH/24/044-Draft 1: Draft Concept Paper for the revision of VICH GL6 (Ecotoxicity Phase 1)
- October 2024: VICH/24/052-Draft 1: Draft Concept Paper for the Revision of GL47 “Studies to Evaluate the Metabolism and Residue Kinetics of Veterinary Drugs in Food-producing Animals: Comparative Metabolism Studies in Laboratory Animals”
- November 2024: VICH/24/076-Draft 1: Draft Concept paper for the revision of VICH GL27 – Guidance on the pre-approval information for registration of new veterinary medicinal products for food-producing animals with respect to antimicrobial resistance – Scientific guideline
Draft Guidelines for Public Consultation
- Stability testing for Medicated Premixes
VICH GL 8(R)
(Quality) – November 2024 – Released at Step 4 for a 6-months consultation period until May 31, 2025 - Studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing
VICH GL 23(R2)
(Safety) – May 2024 – Released at Step 4 for a 6-months consultation period until November 30, 2024 - Pharmaceutical Development: Pharmaceutical Development for Veterinary Medicinal Products
VICH GL 61Quality – February 2024 – Released at Step 4 for a 6-months consultation period until August 15, 2024
- Reproduction: Studies to evaluate the safety of residues of veterinary drug in human food: reproduction studies
VICH GL 22(R)
(Safety) – January 2024 – Released at Step 4 for a 6-months consultation period until July 31, 2024 - GMP for API: Good Manufacturing Practice for Active Pharmaceutical Ingredients used in Veterinary Medicinal Products
VICH GL 60
(Quality) – September 2023 – Released at Step 4 for a 6-months consultation period until March 2024 - Target Animal Safety Evaluation for Veterinary Monoclonal Antibody Products
VICH GL 62
(Biologicals) – August 2025 – Released at Step 4 for a 6-months consultation period until February 15, 2026
Comments Received During Public Consultation
- VICH GL7 (R1) – Comments at Step 4
(Anthelmintics – General) - VICH GL12 (R1) – Comments at Step 4
(Anthelmintics – Bovines) - VICH GL13 (R1) – Comments at Step 4
(Anthelmintics – Ovines) - VICH GL14 (R1) – Comments at Step 4
(Anthelmintics – Caprines) - VICH GL15 (R1) – Comments at Step 4
(Anthelmintics – Equines) - VICH GL16 (R1) – Comments at Step 4
(Anthelmintics – Porcines) - VICH GL18(R2) – Comments at Step 4
(Quality – Impurities) - VICH GL19 (R1) – Comments at Step 4
(Anthelmintics – Canines) - VICH GL20 (R1) – Comments at Step 4
(Anthelmintics – Felines) - VICH GL21 (R1) – Comments at Step 4
(Anthelmintics – Chickens Gallus gallus) - VICH GL50 – Comments at Step 4
(Biologicals: TABST) - VICH GL51 – Comments at Step 4
(Pharmaceuticals – Quality: Stability Data) - VICH GL52 – Comments at Step 4
(Bioequivalence) - VICH GL53 – Comments at Step 4
(EFF) - VICH GL54 – Comments at Step 4
(Safety) - VICH GL56 – Comments at Step 4
(MRK – Honey) - VICH GL59 – Comments at Step 4
(Biologicals – LABST Veterinary Vaccines)